Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionEagle Global Advisors Llc
Latest Disclosed Ownership1,640 shares
Latest Disclosed Value $ 577,034
Eagle Global Advisors Llc ownership in AMGN / Amgen Inc.

On May 15, 2026 - Eagle Global Advisors Llc filed a 13F-HR form disclosing ownership of 1,640 shares of Amgen Inc. (CH:AMGN) valued at $577,034 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 1,640 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 1,640 0 0.00 577 7.65 0.0208
2026-01-28 2025-12-31 13F AMGEN COM 031162100 1,640 -30 -1.80 537 13.80 0.0199
2025-10-28 2025-09-30 13F AMGEN COM 031162100 1,670 0 0.00 471 1.07 0.0181
2025-07-16 2025-06-30 13F AMGEN COM 031162100 1,670 0 0.00 466 -10.38 0.0189
2025-05-12 2025-03-31 13F AMGEN COM 031162100 1,670 0 0.00 520 19.54 0.0214
2025-02-14 2024-12-31 13F AMGEN COM 031162100 1,670 -50 -2.91 435 -21.48 0.0178
2024-11-14 2024-09-30 13F AMGEN COM 031162100 1,720 0 0.00 554 3.17 0.0275
2024-08-14 2024-06-30 13F AMGEN COM 031162100 1,720 -1,000 -36.76 537 -30.53 0.0284
2024-05-15 2024-03-31 13F AMGEN COM 031162100 2,720 0 0.00 773 -1.28 0.0436
2024-02-09 2023-12-31 13F AMGEN COM 031162100 2,720 0 0.00 783 7.11 0.0474
2023-10-30 2023-09-30 13F AMGEN COM 031162100 2,720 0 0.00 731 21.23 0.0474
2023-07-21 2023-06-30 13F AMGEN COM 031162100 2,720 0 0.00 604 -8.22 0.0398
2023-05-08 2023-03-31 13F AMGEN COM 031162100 2,720 0 0.00 658 -7.98 0.0443
2023-02-07 2022-12-31 13F AMGEN COM 031162100 2,720 2,720 714 0.0492
2022-10-24 2022-09-30 13F AMGEN COM 031162100 0 -870 -100.00 0 -100.00
2022-08-11 2022-06-30 13F AMGEN COM 031162100 870 0 0.00 212 0.95 0.0156
2022-04-20 2022-03-31 13F AMGEN COM 031162100 870 870 210 0.0130
2022-02-01 2021-12-31 13F AMGEN COM 031162100 0 -50,535 -100.00 0 -100.00
2021-11-15 2021-09-30 13F AMGEN COM 031162100 50,535 -704 -1.37 10,746 -13.96 0.7094
2021-07-15 2021-06-30 13F AMGEN COM 031162100 51,239 156 0.31 12,490 -1.73 0.8077
2021-05-07 2021-03-31 13F AMGEN COM 031162100 51,083 -425 -0.83 12,710 7.32 0.9386
2021-02-01 2020-12-31 13F AMGEN COM 031162100 51,508 -1,735 -3.26 11,843 -12.48 0.9319
2020-10-22 2020-09-30 13F AMGEN COM 031162100 53,243 -1,519 -2.77 13,532 4.77 1.2166
2020-08-14 2020-06-30 13F AMGEN COM 031162100 54,762 -384 -0.70 12,916 15.53 1.1662
2020-05-06 2020-03-31 13F AMGEN COM 031162100 55,146 987 1.82 11,180 -14.37 1.1331
2020-02-06 2019-12-31 13F AMGEN COM 031162100 54,159 -1,305 -2.35 13,056 21.64 0.6603
2019-11-14 2019-09-30 13F AMGEN COM 031162100 55,464 871 1.60 10,733 6.69 0.4601
2019-08-13 2019-06-30 13F AMGEN COM 031162100 54,593 -10,160 -15.69 10,060 -18.22 0.4024
2019-04-22 2019-03-31 13F AMGEN COM 031162100 64,753 -304 -0.47 12,302 -2.87 0.4805
2019-01-30 2018-12-31 13F AMGEN COM 031162100 65,057 34,201 110.84 12,665 98.01 0.5484
2018-11-13 2018-09-30 13F AMGEN COM 031162100 30,856 1,290 4.36 6,396 17.19 0.1990
2018-07-31 2018-06-30 13F AMGEN COM 031162100 29,566 371 1.27 5,458 9.66 0.1726
2018-05-04 2018-03-31 13F AMGEN COM 031162100 29,195 4,604 18.72 4,977 16.39 0.1718
2018-02-12 2017-12-31 13F AMGEN COM 031162100 24,591 880 3.71 4,276 -3.28 0.1336
2017-11-13 2017-09-30 13F AMGEN COM 031162100 23,711 840 3.67 4,421 12.24 0.1335
2017-07-27 2017-06-30 13F AMGEN COM 031162100 22,871 4,567 24.95 3,939 31.17 0.1127
2017-05-09 2017-03-31 13F AMGEN COM 031162100 18,304 3,514 23.76 3,003 38.90 0.0811
2017-02-14 2016-12-31 13F AMGEN COM 031162100 14,790 -27,579 -65.09 2,162 -69.41 0.0590
2016-11-14 2016-09-30 13F AMGEN COM 031162100 42,369 -329 -0.77 7,068 8.79 0.1998
2016-08-15 2016-06-30 13F AMGEN COM 031162100 42,698 46 0.11 6,497 1.59 0.1907
2016-05-16 2016-03-31 13F AMGEN COM 031162100 42,652 -45 -0.11 6,395 -7.73 0.2301
2016-02-16 2015-12-31 13F AMGEN COM 031162100 42,697 -5,154 -10.77 6,931 4.71 0.2407
2015-11-16 2015-09-30 13F AMGEN COM 031162100 47,851 26,695 126.18 6,619 103.79 0.2192
2015-08-14 2015-06-30 13F AMGEN COM 031162100 21,156 -544 -2.51 3,248 -6.37 0.0842
2015-05-15 2015-03-31 13F AMGEN COM 031162100 21,700 320 1.50 3,469 1.85 0.0907
2015-02-09 2014-12-31 13F AMGEN COM 031162100 21,380 21,380 3,406 0.0870
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.